18 results on '"Qudeimat, Amr"'
Search Results
2. Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL
3. Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic Malignancy
4. Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS
5. Intrapulmonary administration of recombinant activated factor VII in pediatric, adolescent, and young adult oncology and hematopoietic cell transplant patients with pulmonary hemorrhage.
6. Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution
7. Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric Patients
8. Comparison of Haemonetics Cell Saver 5+ and manual density separation for optimum depletion of red blood cells and preservation of CD34+ cells in major ABO-incompatible bone marrow grafts.
9. Interplay Effect of Splenic Motion for Total Lymphoid Irradiation in Pediatric Proton Therapy.
10. Outcomes following intolerance to calcineurin inhibitor‐based graft‐versus‐host disease prophylaxis in children after allogeneic hematopoietic cell transplantation.
11. Pulmonary Complications in Children Following Hematopoietic Cell Transplantation: A Case Report and Review of the Diagnostic Approach.
12. Effectiveness of Bath Wipes After Hematopoietic Cell Transplantation: A Randomized Trial.
13. Multiple NDM-5-Expressing Escherichia Coli Isolates From an Immunocompromised Pediatric Host.
14. Autologous CD19-CAR T-Cells for the Treatment of Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients: An initial Report from an Institutional Phase I/II Study.
15. Second Allogeneic Hematopoietic Cell Transplant Is a Successful Salvage Modality for Pediatric Patients Who Relapse after First Transplant.
16. Haploidentical CD45RA-Negative Donor Lymphocyte Infusions Are Feasible, Safe and Associated with Clinical Benefit.
17. 582 - Infused Total Nucleated Cell Dose is a Better Predictor of Transplant Outcomes Than CD34+ Cell Dose for Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Children.
18. 413 - Allogeneic Hematopoietic Cell Transplantation for Acute Megakaryoblastic Leukemia: A Single Center Experience.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.